Stocktoria

QIAGEN N.V. QGEN

NYSE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1996-09-01 · LEI

QIAGEN N.V. statistics & valuation

Market cap$8.1B
P / E19.1×
P / S3.9×
P / B2.1×
P / FCF17.9×
Dividend yield0.67%
Net margin20.3%
Return on equity11.2%
FCF margin21.7%
Net debt$815.4M
Net debt / EBITDA1.2×
Enterprise value USD$8.9B
EV / EBITDA13.5×
Earnings yield EBIT/EV5.2%
Return on capital8.1%
Graham number -36.2%$27.45

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($27.45); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
6.00% 2.80% 12.70% -2.70% 19.20% 22.80% 19.80% 17.40% 4.20% 20.30% 2016201720182019202020212022202320242025
Gross margin (%)
63.10% 65.10% 66.60% 65.90% 65.90% 64.40% 64.70% 62.80% 48.90% 62.20% 2016201720182019202020212022202320242025
Operating margin (%)
7.40% 10.80% 17.80% -1.70% 20.70% 28.00% 24.80% 20.90% 4.90% 22.30% 2016201720182019202020212022202320242025
Return on equity (%)
3.10% 1.60% 7.20% -1.60% 12.80% 16.60% 12.20% 9.00% 2.30% 11.20% 2016201720182019202020212022202320242025
Shares outstanding
239.0M 233.0M 233.5M 227.8M 234.2M 232.0M 230.1M 230.6M 224.7M 218.9M 2016201720182019202020212022202320242025
Net debt ($)
$627.9M $1.10B $1.02B $1.08B $1.32B $1.06B $1.13B $841.7M $728.0M $815.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
1.90% 0.80% 3.30% -0.80% 6.10% 8.30% 6.70% 5.60% 1.50% 6.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
20.00% 13.90% 16.60% 13.90% 17.40% 19.90% 27.40% 15.80% 25.60% 21.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.41× 0.69× 0.83× 0.67× 0.69× 0.63× 0.54× 0.40× 0.39× 0.44× 2016201720182019202020212022202320242025
EPS ($)
$0.34 $0.17 $0.82 -$0.18 $1.53 $2.21 $1.84 $1.48 $0.37 $1.94 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

QIAGEN N.V. trades at about 22.2× earnings — below its 10-year norm (10-year range 23.1×–203.3×, median 44.3×).

22.2× 203.3×

Shaded band = 10-year range (23.1×–203.3×); dot = today's 22.2×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin62.2%48.9%62.8%64.7%64.4%65.9%65.9%66.6%65.1%63.1%
Operating margin22.3%4.9%20.9%24.8%28.0%20.7%-1.7%17.8%10.8%7.4%
Net margin20.3%4.2%17.4%19.8%22.8%19.2%-2.7%12.7%2.8%6.0%
FCF margin21.7%25.6%15.8%27.4%19.9%17.4%13.9%16.6%13.9%20.0%
Return on assets6.8%1.5%5.6%6.7%8.3%6.1%-0.8%3.3%0.8%1.9%
Return on equity11.2%2.3%9.0%12.2%16.6%12.8%-1.6%7.2%1.6%3.1%
Debt / equity0.44×0.39×0.40×0.54×0.63×0.69×0.67×0.83×0.69×0.41×
Current ratio3.901.881.992.461.392.841.652.225.073.36

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.